Autoradiographic demonstration of loss of α 2-adrenoceptors in progressive supranuclear palsy: preliminary report

We assessed, by quantitative autoradiography in tissue sections, the density of alpha 2-adrenoceptors in several representative brain regions from a typical progressive supranuclear palsy (PSP) patient and in 9 matched brains. The full agonist 3H-bromoxidine was used as a ligand. The density of alpha 2-receptors was dramatically reduced in all the examined brain areas of this PSP patient as compared to the control group. The locus ceruleus degeneration observed here is the most plausible explanation for this loss of alpha 2-receptors. Our data show that abnormalities in the noradrenergic system may justify some clinical features of the PSP clinical picture, this supporting the idea of further study of the clinical effects of noradrenergic drugs in PSP.

[1]  S. Nagataki,et al.  Pure akinesia: an atypical manifestation of progressive supranuclear palsy. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[2]  Michael J. Kuhar,et al.  Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors , 1982, Journal of Neuroscience Methods.

[3]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .

[4]  D. Charney,et al.  Alpha-2 Adrenergic Receptor Sensitivity and the Mechanism of Action of Antidepressant Therapy , 1983, British Journal of Psychiatry.

[5]  Á. Díaz,et al.  Regionally specific age-dependent decline in α 2-adrenoceptors: An autoradiographic study in human brain , 1991, Neuroscience Letters.

[6]  Y. Agid,et al.  Adrenergic receptors in Parkinson's disease , 1984, Brain Research.

[7]  K. Starke,et al.  Modulation of neurotransmitter release by presynaptic autoreceptors. , 1989, Physiological reviews.

[8]  S. Kish,et al.  Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers , 1985, Annals of neurology.

[9]  E. Hirsch,et al.  Dopaminergic and cholinergic lesions in progressive supranuclear palsy , 1985, Annals of neurology.

[10]  Á. Pazos,et al.  α2-Adrenoceptors in human forebrain: autoradiographic visualization and biochemical parameters using the agonist [3H]UK-14304 , 1988, Brain Research.

[11]  Á. Pazos,et al.  Dopamine D1 and D2 receptors in progressive supranuclear palsy: An autoradiographic study , 1992, Annals of neurology.

[12]  J. Steele Progressive supranuclear palsy. , 1972, Brain : a journal of neurology.

[13]  Á. Pazos,et al.  Quantitative light microscopic autoradiographic localization of α 2-adrenoceptors in the human brain , 1992, Brain Research.